Aurobindo Pharma plans to raise funds from global markets

06 Jul 2005

1

Hyderabad: Aurobindo Pharma (APL) plans to raise $60 million (Rs264 crore) from the global markets.

Recently the company received four US Food and Drug Administration approvals for its generic anti-retroviral drugs (ARVs), which are expected to open up huge global business opportunities.

The funds from the proposed issue would be utilised for new projects, the modernisation and expansion of existing plants, overseas direct investment in joint ventures or wholly-owned subsidiaries, acquisitions and other purposes, including repaying of existing loans.

The company proposes to list the foreign currency convertible bonds (FCCBs) on one or more foreign stock exchanges and convert them into equity shares at a conversion price to be decided between the company and overseas investors.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers